Big Sioux Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Big Sioux Wealth Management's RXRX Position: Q3 2026 in Review
Big Sioux Wealth Management sold out of Recursion Pharmaceuticals (RXRX) in Q3 2026, closing a stake of 290 shares — an estimated $1.06K sold.
Big Sioux Wealth Management first reported a position in RXRX in Q4 2025 and held it in 3 quarters. The position peaked at $1.19K in Q4 2025. 353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Big Sioux Wealth Management reported no remaining Recursion Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Big Sioux Wealth Management sold 290 Recursion Pharmaceuticals shares in Q3 2026, an estimated $1.06K.
- Big Sioux Wealth Management first reported a position in Recursion Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Big Sioux Wealth Management's Recursion Pharmaceuticals position peaked at $1.19K in Q4 2025.
- 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.